As conversion of LC3-I to LC3-II and formation of LC3 puncta have been generally used as indicators of autophagy [22], we employed them to determine whether NCL1 treatment induced autophagy in prostate cancer cells. The gene discussed is CAPN3; the disease is prostate carcinoma.